Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...

Quantified preferences favored higher lesion growth rate reduction (10%→50% at 18 months) as the primary driver across all ...

A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B ...

Retinoblastoma is the most common primary intraocular malignancy in children, affecting roughly 1 in 15,000 to 20,000 live ...

A new international expert consensus statement published in The Lancet Respiratory Medicine provides guidance for doctors on ...

PTSD is not a battlefield cliché or a character flaw, but a survivable injury of the nervous system that demands early recognition, competent treatment, and a culture willing to stop letting warriors ...

Learn about common triggers for rheumatoid arthritis flares, including environmental, physiological, and emotional factors, ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

Ramdongbang, A. and Charoenkankar, S. (2026) Intradermal hUC-MSC Therapy for Infraorbital Wrinkles and Nasolabial Fold Aging: ...

Perioperative anemia and red blood cell transfusions are important risk factors for morbidity and mortality in cardiac ...

Aim This study investigated the influence of depression status on lipid lowering therapy (LLT) prescribing and achievement of ...